Current heart failure therapeutics affects symptoms withoutappreciably reducing the mortality rate of 50% in five years --suggesting a failure in treating the underlying mechanism. Thisbook proposes a new mechanism for heart failure; immune mediatedcardiac remodelling for cardiac dysfunction.
The outstanding editor team of two internationally recognizedimmunologists -- Ronald Watson, who has studied heart disease inimmune dysfunction for a decade and has a patent for animmunotherapy of heart disease by immune regulation, and DouglasLarson, whose experience in cardiac transplantation immunology hasprovided the foundation for research into novel therapeutics forheart failure and hypertension - makes Immune Dysfunction andImmunotherapy in Heart Disease the definitive reference to thestate of the science in this area.
The four parts of the book address:
* * Immune Dysfunction Leading to Heart Disease: Induction byPhysiological Changes
* Immune Dysfunction Promoting CVD: Induction by TransplantationDrugs
* Immune Dysfunction Leading to Heart Dysfunction: Induction orPrevention by Cardiotherapeutic Drugs
* Immune Dysfunction Leading to Heart Disease: Induction byPathogens
Both researchers and practitioners will find this authoritativevolume an excellent source of information on novel immune targetedtherapeutics.
Ronald Ross Watson
Allergieforschung u. Klinische Immunologie Allergy & Clinical Immunology Cardiovascular Disease Kardiovaskuläre Erkrankung Kardiovaskuläre Erkrankungen Medical Science Medizin